# Combination Chemotherapy in Treating Patients With Primary Peritoneal or Stage III Epithelial Ovarian Cancer

> **NCT00003322** · PHASE3 · COMPLETED · sponsor: **Gynecologic Oncology Group** · enrollment: 384 (estimated)

## Conditions studied

- Ovarian Cancer
- Primary Peritoneal Cavity Cancer

## Interventions

- **DRUG:** cisplatin
- **DRUG:** paclitaxel
- **PROCEDURE:** quality-of-life assessment

## Key facts

- **NCT ID:** NCT00003322
- **Lead sponsor:** Gynecologic Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-03
- **Primary completion:** 2006-01
- **Final completion:** —
- **Target enrollment:** 384 (ESTIMATED)
- **Last updated:** 2013-05-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003322

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003322, "Combination Chemotherapy in Treating Patients With Primary Peritoneal or Stage III Epithelial Ovarian Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00003322. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*